Form 8-K - Current report:
SEC Accession No. 0001055726-24-000053
Filing Date
2024-11-14
Accepted
2024-11-14 16:07:57
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ino-20241114.htm   iXBRL 8-K 37132
2 EX-99.1 ino-93024x8kex991.htm EX-99.1 98629
6 picture3.jpg GRAPHIC 20543
  Complete submission text file 0001055726-24-000053.txt   303943

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ino-20241114.xsd EX-101.SCH 1764
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ino-20241114_lab.xml EX-101.LAB 22534
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ino-20241114_pre.xml EX-101.PRE 13035
17 EXTRACTED XBRL INSTANCE DOCUMENT ino-20241114_htm.xml XML 2824
Mailing Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121
Business Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 241462077
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)